News items for the in vitro diagnostics industry for the week of Jan. 13, 2020.
Within diagnostics, Beckman Coulter saw core revenue growth in the low-single digits, while Cepheid was up in the double digits for the quarter.
The company's Life Sciences segment was up 17 percent year over year, while its Diagnostics business grew 8 percent.
IDT will operate as a standalone company within Danaher's Life Sciences segment after the close of the deal, which is expected to occur in mid-2018.
The Hereditary Cancer Solution combines target capture probes from Integrated DNA Technologies with specialized analytics developed by Sophia.